+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Risedronate"

Osteoporosis Drugs Market Report 2025 - Product Thumbnail Image

Osteoporosis Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Bisphosphonates Global Market Report 2025 - Product Thumbnail Image

Bisphosphonates Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Bisphosphonate Drug Global Market Report 2025 - Product Thumbnail Image

Bisphosphonate Drug Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Paget Disease Treatment Market Report 2025 - Product Thumbnail Image

Paget Disease Treatment Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
From
Osteoporosis Treatment Market Report 2025 - Product Thumbnail Image

Osteoporosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Postmenopausal Osteoporosis Treatment Market Report 2025 - Product Thumbnail Image

Postmenopausal Osteoporosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Postmenopausal Osteoporosis - Pipeline Insight, 2025 - Product Thumbnail Image

Postmenopausal Osteoporosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Osteoporosis Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Osteoporosis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
  • 16 Results (Page 1 of 1)
Loading Indicator

Risedronate is a medication used to treat and prevent osteoporosis, a condition characterized by weak and brittle bones. It belongs to a class of drugs known as bisphosphonates, which work by slowing down the rate of bone breakdown and increasing bone density. Risedronate is also used to treat Paget's disease of bone, a disorder that causes abnormal bone growth and pain. It is available in both oral and intravenous forms. Risedronate is a widely used drug in the Endocrine and Metabolic Disorders Drugs market. It is used to treat and prevent osteoporosis, a condition that affects millions of people worldwide. It is also used to treat Paget's disease of bone, a rare disorder that causes abnormal bone growth and pain. Risedronate is generally well-tolerated and has few side effects. Some companies in the Risedronate market include Merck & Co., Inc., Teva Pharmaceuticals, and Mylan N.V. These companies manufacture and distribute the drug in various forms, including tablets, capsules, and injections. Show Less Read more